Reach doctors and patients through trusted health voices in the UAE
We manage end-to-end influencer campaigns for pharmaceutical brands – from compliant briefs and DHA-approved content to measurable ROI. Your next campaign starts here.
Why pharma brands choose BrandStory
Key takeaways for your pharma influencer strategy
- Compliance is non-negotiable The UAE's healthcare regulator (DHA) requires all promotional content to be pre-approved. We embed compliance into every step of campaign creation, from influencer briefing to final content review.
- Choose the right voices Not all influencers are suitable for pharma. We select healthcare professionals (HCPs) and patient advocates with relevant specialities, active patients and a transparent disclosure practice.
- Content must educate, not just advertise The most effective pharma influencer campaigns provide genuine health education. Our content briefs focus on disease awareness, treatment options and patient support – not just product promotion.
- Measurement goes beyond likes We track referral traffic to your brand website, coupon code redemptions, patient enquiries and shifts in physician prescribing patterns where data is available.
- Localisation matters Arabic-language content, culturally sensitive messaging and awareness of local health priorities (e.g., diabetes, obesity, cardiovascular disease) are essential for relevance.
Built for pharma, regulated for the UAE
BrandStory is a specialist influencer marketing agency that focuses exclusively on the healthcare and pharmaceutical sector in the UAE. We don't do fashion or lifestyle – we work with brands that need regulatory certainty.
Our team includes former DHA compliance officers, healthcare marketers and digital strategists who understand the unique constraints of pharmaceutical promotion in the Emirates. We've managed campaigns for multinational pharma companies, local generics manufacturers and specialist clinics.
Every influencer we partner with is contracted to follow a strict code of conduct. All content is drafted, reviewed and stored in a compliance-ready format. You receive a full audit trail for each post, including the original DHA approval reference.
End-to-end pharma influencer marketing
Each service is tailored for pharmaceutical brands operating under UAE healthcare regulations. We handle the complexity so your message reaches the right audience safely.
Influencer identification & vetting
We find healthcare professionals and patient advocates whose speciality aligns with your therapeutic area. Each candidate undergoes credential verification, background check and social media audit before onboarding.
Discuss ServiceCompliant content creation
Our content team drafts posts, stories, videos and articles that meet DHA promotional standards. We include mandatory safety information, fair balance statements and clear disclosure labels.
Discuss ServiceDHA submission & approval management
We prepare and submit all campaign materials to the relevant health authority. Our average approval turnaround is five working days. If revisions are required, we handle them directly.
Discuss ServiceCampaign execution & monitoring
Once approved, we coordinate posting schedules, manage influencer relationships and monitor engagement in real time. We flag any negative comments or off-script deviations immediately.
Discuss ServicePerformance reporting & ROI
Monthly dashboards show reach, engagement, website referrals, coupon use and physician mentions. Where possible, we correlate campaign activity with prescription data to measure true impact.
Discuss ServiceCompliance training for internal teams
We train your marketing and medical affairs teams on UAE influencer regulations, disclosure requirements and best practices for working with HCPs in digital spaces.
Discuss ServiceProven impact for pharma brands
Here is how we have helped pharmaceutical companies achieve their marketing goals while staying fully compliant.
A multinational diabetes brand wanted to launch a new insulin device. Standard detailing was not enough. We identified three endocrinologists and two patient advocates with strong Instagram and YouTube followings in the UAE. The campaign reached 1.2 million users and generated 15,000 clicks to the brand's patient support website.
A local generics manufacturer needed to increase awareness of its antibiotic range among GPs. We ran a series of Instagram Lives and LinkedIn posts featuring a clinical pharmacist. Within three months, 22% of surveyed GPs said they were more likely to prescribe the brand after seeing the campaign.
A private hospital group wanted to build trust for its weight management programme. We partnered with a registered dietitian who shared recipe videos and patient success stories (with consent). The campaign led to 340 consultation bookings in six weeks.
Compliance benchmark: All three campaigns passed DHA review with no major revisions. Our average approval time is 4.8 working days across all therapeutic areas.
Influencer retention: 85% of HCPs we contract choose to work with us again. Payment terms are clear, content expectations are respected and professional boundaries are maintained.
Brand safety: We have never had a campaign suspended for regulatory non-compliance. Our proactive monitoring catches potential issues before they escalate.
How we vet influencers for pharma compliance
Pharma influencer marketing requires a different standard of vetting. Every person in our network is evaluated across six criteria before we include them in any proposal.
First, we verify professional credentials. For healthcare professionals, that means checking active DHA/HAAD licensing, speciality board certifications and employment history. For patient advocates, we confirm their diagnosis or experience is authentic and they are not currently receiving undisclosed payments from competitor brands.
Second, we review their social media history. We look for past content related to health, any regulatory warnings, and their approach to disclosure. We also run a sentiment scan to ensure they hold no extreme or unsubstantiated medical views that could harm your brand. Only those who pass all checks proceed to a formal briefing.
Influencer marketing vs. conventional pharma advertising
Traditional pharma marketing (print, TV, detailing) is still valuable, but it has limitations in reach and trust.
Conventional pharma advertising relies on one-way communication. Your brand pushes a message, and the audience can choose to engage or not. In the UAE, print and TV ads lose impact as more consumers shift to digital. Detailing is effective but expensive per contact and does not scale easily.
Influencer marketing turns the model around. A trusted health professional recommends your product to their community. The audience perceives it as a personal recommendation rather than an advert. The engagement rates are typically 2-5 times higher than traditional digital display ads.
Additionally, influencer content can be repurposed across your own channels, used in patient education materials, and is more likely to be shared organically. With proper compliance, it is a scalable, trust-building channel that complements your existing promotional mix.
Choose the right package for your pharma influencer campaign Comparison & Deliverables
All packages include our standard compliance workflow. Prices are indicative and vary based on scope, therapeutic area and number of influencers.
| Features & Deliverables |
Starter
Ideal for single-product launches or short educational campaigns
Select Plan
|
MOST POPULAR
Growth
Designed for multi-brand campaigns or longer engagement periods
Select Plan
|
Enterprise
Full-scale programmes with dedicated account manager and priority DHA handling
Select Plan
|
|---|---|---|---|
| Number of influencers | 1-2 | 3-5 | 6+ |
| Campaign duration | 4 weeks | 8-12 weeks | 6 months or ongoing |
| DHA submission & revisions | Up to 2 revisions | Unlimited revisions | Express lane + unlimited |
| Content formats | Static posts & stories | Includes video & carousel | Full mix + livestreams |
| Reporting frequency | Final report only | Bi-weekly dashboards | Real-time dashboard + weekly calls |
| Influencer vetting & training | Basic credential check | Full vetting + compliance training | All inclusive + ongoing monitoring |
| Creative strategy | Content brief provided | Custom creative strategy session | Dedicated strategist on retainer |
| Brand safety monitoring | Manual check after posting | Daily automated monitoring | 24-hour live monitoring team |
| Compliance archive & audit trail | Basic record keeping | Searchable compliance folder | Full audit-ready archive per post |
All packages subject to applicable taxes. Custom packages available for generics, OTC and specialty pharma. We also offer standalone compliance services for in-house campaigns. Schedule a consultation.
Regulatory compliance for pharma influencer marketing in the UAE
Every pharmaceutical advertisement in the UAE must comply with federal and emirate-level regulations. We build compliance into every stage of your campaign.
The Dubai Health Authority (DHA) and the Health Authority - Abu Dhabi (HAAD) both require that all promotional content for medicines and health services is pre-approved. This includes influencer posts, stories, videos and even comments on live streams. The content must include mandatory safety information, fair balance statements and clear disclosure that the post is a paid partnership.
BrandStory's compliance process starts at influencer selection. We ensure each influencer's contract includes a clause requiring them to follow DHA guidelines. All content drafts are reviewed by our compliance team, and we submit the final materials to the relevant authority before they are published. We keep a complete audit trail for each post, including the DHA approval reference, which your team can access at any time.
How influencer marketing works with your existing pharma strategy
Influencer marketing is not a standalone channel. It works best when integrated with your broader marketing and medical communications.
The content created for influencer campaigns can be repurposed for your brand's social media channels, patient education websites and even as part of digital detailing for HCPs. For example, a video created with a physician influencer can be used in a symposium or shared with sales reps to show how the product is discussed online.
We also coordinate with your medical affairs and compliance teams to ensure alignment with global brand guidelines. Our campaigns are designed to support your brand's core messages without creating duplication or regulatory conflict. We can even help you develop a global-to-local content adaptation framework. Explore our integrated pharma marketing approach.
Industries we serve
Our experience covers a range of pharmaceutical and healthcare segments in the UAE.
Pharma influencer marketing in the UAE: 2025 to 2026
The landscape is evolving quickly. Here are the key shifts we are seeing in the UAE market.
| Trend Area | 2025 Baseline | 2026 Evolution |
|---|---|---|
| Regulatory clarity | 2025: Ad hoc enforcement with some ambiguity on influencer disclosures | 2026: DHA issues explicit influencer marketing guidelines; all posts must include a standardised disclosure hashtag |
| Influencer specialisation | 2025: General health influencers (dermatologists, dentists) | 2026: Rise of sub-specialty influencers (oncologists, diabetologists, nephrologists) with niche audiences |
| Content formats | 2025: Static posts and short videos dominate | 2026: Livestream Q&As, long-form educational series and interactive polls gain traction |
| Measurement sophistication | 2025: Basic reach and engagement metrics | 2026: Integration with prescription data and patient journey analytics |
| Patient advocacy | 2025: Few patient influencers in UAE pharma campaigns | 2026: Growth in approved patient ambassador programmes with strict compliance oversight |
| AI in compliance | 2025: Manual review of all content drafts | 2026: AI-powered compliance checks pre-submission, reducing review time by 40% |
Common questions about pharma influencer marketing in the UAE
We receive these questions from pharmaceutical brands considering influencer marketing for the first time.
Is influencer marketing allowed for prescription medicines in the UAE?
Yes, but only if the content is non-promotional to consumers and directed only at healthcare professionals. If you want to reach patients, you must use unbranded disease awareness content. We can help you design a campaign that stays within these boundaries.
How long does DHA approval take for influencer content?
Typically 5-7 working days for first-time submissions. With our pre-submission compliance checks, most materials pass on the first review. If revisions are needed, we turn them around within 2 days. For priority submissions, we can reduce this to 3 working days.
What happens if an influencer posts something off-script?
Our campaign monitoring includes real-time alerts for any unscheduled posts or language deviations. We immediately contact the influencer and coordinate takedown if required. We also include penalty clauses in contracts to protect your brand.
Can you work with international pharma brands that have global compliance guidelines?
Yes. We regularly work with multinational pharma companies that have their own global review processes. We map our UAE compliance workflow to your internal procedures and provide all necessary documentation for your medical, legal and regulatory teams.
What types of influencers do you work with?
We work with licensed healthcare professionals (physicians, pharmacists, nurses, dietitians) and vetted patient advocates. We do not work with general lifestyle influencers for pharma campaigns because they lack the necessary medical authority and compliance awareness.
How do you measure success for a pharma influencer campaign?
We tie campaign metrics to your objectives. For awareness, we track reach and engagement. For education, we measure clicks to patient resources and time spent on content. For commercial impact, we look at coupon redemptions, clinic bookings and, where data sharing is possible, prescription-level data from pharmacy partners.
